Search

everythinglearnresearchcommunity

for

Search:↓

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Plucked hair follicles can help diagnose scalp lupus.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

PCOS involves genetic and immune factors, especially T cells, affecting its development.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

taVNS reduces vitiligo symptoms in mice.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Sparse hairless patches can develop and stabilize in alopecia areata under certain conditions.